Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology
由日本临床肿瘤学会/日本内科肿瘤学会牵头，日本儿科血液学/肿瘤学会合作制定的关于在成人和儿童神经营养受体酪氨酸激酶融合阳性晚期实体瘤患者中诊断和使用原肌球蛋白受体激酶抑制剂的临床建议。
期刊:International Journal of Clinical Oncology
影响因子:2.8
doi:10.1007/s10147-019-01610-y
Naito, Yoichi; Mishima, Saori; Akagi, Kiwamu; Igarashi, Ataru; Ikeda, Masafumi; Okano, Susumu; Kato, Shunsuke; Takano, Tadao; Tsuchihara, Katsuya; Terashima, Keita; Nishihara, Hiroshi; Nishiyama, Hiroyki; Hiyama, Eiso; Hirasawa, Akira; Hosoi, Hajime; Maeda, Osamu; Yatabe, Yasushi; Okamoto, Wataru; Ono, Shigeru; Kajiyama, Hiroaki; Nagashima, Fumio; Hatanaka, Yutaka; Miyachi, Mitsuru; Kodera, Yasuhiro; Yoshino, Takayuki; Taniguchi, Hiroya
